Application of systemic treatment in conversion therapy options for liver cancer

9Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Radical hepatectomy is the main treatment method to improve the prognosis of patients with intermediate and early-stage liver cancer. Most liver cancer patients in China are in the advanced stage at the initial diagnosis, losing the opportunity for surgical treatment. Therefore, it is essential to down-stage unresectable liver cancer to resectable liver cancer clinically, which is an important way to improve patients’ survival and a hotspot of current clinical research. In recent years, with the increase in effective treatment methods for liver cancer, the resection rate of conversion surgery for unresectable advanced liver cancer has been significantly improved, and a growing number of patients benefit from conversion therapy. This article mainly reviews the connotation of conversion therapy for liver cancer, the patient selection, the selection of conversion strategy, the timing of sequential operations, the scheme and safety, etc.

Cite

CITATION STYLE

APA

Bei, H., Mai, W., Chen, W., Li, M., & Yang, Y. (2022, October 6). Application of systemic treatment in conversion therapy options for liver cancer. Frontiers in Oncology. Frontiers Media S.A. https://doi.org/10.3389/fonc.2022.966821

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free